chr5-44809446-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000507110.6(MRPS30):āc.484C>Gā(p.Arg162Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000628 in 1,613,770 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000507110.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPS30 | NM_016640.4 | c.484C>G | p.Arg162Gly | missense_variant | 1/5 | ENST00000507110.6 | NP_057724.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPS30 | ENST00000507110.6 | c.484C>G | p.Arg162Gly | missense_variant | 1/5 | 1 | NM_016640.4 | ENSP00000424328.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000321 AC: 80AN: 249344Hom.: 1 AF XY: 0.000347 AC XY: 47AN XY: 135268
GnomAD4 exome AF: 0.000666 AC: 973AN: 1461462Hom.: 2 Cov.: 32 AF XY: 0.000703 AC XY: 511AN XY: 727044
GnomAD4 genome AF: 0.000263 AC: 40AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.484C>G (p.R162G) alteration is located in exon 1 (coding exon 1) of the MRPS30 gene. This alteration results from a C to G substitution at nucleotide position 484, causing the arginine (R) at amino acid position 162 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at